SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD

Overview

SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering DEGARELIX ACETATE; LINACLOTIDE; LIRAGLUTIDE; SEMAGLUTIDE.

API / Drug Master Files

SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LIRAGLUTIDEActive2026-02-09
• DEGARELIX ACETATEActive2025-12-16
• LINACLOTIDEActive2025-09-23
• SEMAGLUTIDEActive2023-03-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.